CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-10 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $13.16 | $658K | 1,148,499 |
| 2024-12-06 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Option exercise | +13,789 | $1.44 | $20K | 3,421,636 |
| 2024-12-06 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Option exercise | +11,876 | $8.42 | $100K | 3,433,512 |
| 2024-12-06 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Option exercise | +11,876 | $8.42 | $100K | 4,327,189 |
| 2024-12-06 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) | −13,789 | 20,684 | ||
| 2024-12-06 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) | −11,876 | 338,124 | ||
| 2024-12-06 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) | −11,876 | 1,088,124 | ||
| 2024-12-06 | Lowenthal Richard E PRESIDENT AND CEO | Option exercise | +11,876 | $8.42 | $100K | 4,327,189 |
| 2024-12-06 | Lowenthal Richard E PRESIDENT AND CEO | Option exercise | +13,789 | $1.44 | $20K | 3,421,636 |
| 2024-12-06 | Lowenthal Richard E PRESIDENT AND CEO | Option exercise | +11,876 | $8.42 | $100K | 3,433,512 |
| 2024-12-06 | Lowenthal Richard E PRESIDENT AND CEO | Option exercise · Stock Option (right to buy) | −11,876 | 1,088,124 | ||
| 2024-12-06 | Lowenthal Richard E PRESIDENT AND CEO | Option exercise · Stock Option (right to buy) | −13,789 | 20,684 | ||
| 2024-12-06 | Lowenthal Richard E PRESIDENT AND CEO | Option exercise · Stock Option (right to buy) | −11,876 | 338,124 | ||
| 2024-12-06 | Chakma Justin Chief Business Officer | Option exercise | +50,000 | $0.84 | $42K | 186,380 |
| 2024-12-06 | Chakma Justin Chief Business Officer | Sale | −50,000 | $14.23 | $712K | 136,380 |
| 2024-12-06 | Chakma Justin Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −50,000 | 50,000 | ||
| 2024-12-05 | Chakma Justin Chief Business Officer | Option exercise | +49,640 | $0.84 | $42K | 186,020 |
| 2024-12-05 | Chakma Justin Chief Business Officer | Sale | −49,640 | $14.13 | $702K | 136,380 |
| 2024-12-05 | Chakma Justin Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −49,640 | 100,000 | ||
| 2024-12-04 | Chakma Justin Chief Business Officer | Option exercise | +45,000 | $0.84 | $38K | 181,380 |
Page 7 of 14 · 267 trades